← Eichor
Study identifier: NCT05084339 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Glucose Homeostasis, Metabolomics and Pregnancy Outcomes After Bariatric Surgery

Condition: Bariatric Surgery Status Complicating Pregnancy  ·  Sponsor: Universitaire Ziekenhuizen KU Leuven

PhaseN/A
Planned participants190
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersYes

About this study

The aim of the GLORIA study is to determine whether an altered glucose metabolism (with more hypoglycaemia and glycaemic variability) and altered metabolomics during pregnancy after bariatric surgery contribute to the increased risk for adverse pregnancy outcomes such as small-for-gestational age infants. In addition, the investigators also aim to evaluate whether continuous glucose monitoring (CGM) can be used to diagnose gestational diabetes (GDM).

This description comes directly from the study's public registry record.

Talk to the study team

Katrien Benhalima, MD PhD  ·  +3216340614  ·  katrien.benhalima@uzleuven.be

Ellen Deleus, MD  ·  ellen.deleus@uzleuven.be

Always discuss trial participation with your own doctor first.

Locations (8)

OLV-Aalst-AsseAalst, BelgiumRecruiting
UZAAntwerp, BelgiumRecruiting
ZNA AntwerpenAntwerp, BelgiumRecruiting
Imelda BonheidenBonheiden, BelgiumRecruiting
AZ St-Jan BruggeBruges, BelgiumRecruiting
UZ GentGhent, BelgiumRecruiting
AZ Groeninge KortrijkKortrijk, BelgiumRecruiting
UZ LeuvenLeuven, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05084339